Cargando…

Signal Transduction Pathways (MAPKs, NF-κB, and C/EBP) Regulating COX-2 Expression in Nasal Fibroblasts from Asthma Patients with Aspirin Intolerance

BACKGROUND: Recent studies have revealed that cyclooxygenase-2 (COX-2) expression is down-regulated in aspirin-induced asthma (AIA). Various signal pathways (MAPKs, NF-κB and C/EBP) are involved in COX-2 regulation. OBJECTIVE: To investigate the regulation of COX-2 expression through MAP-kinase path...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Garcia, Francesc Josep, Mullol, Joaquim, Perez-Gonzalez, Maria, Pujols, Laura, Alobid, Isam, Roca-Ferrer, Jordi, Picado, Cesar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519844/ https://www.ncbi.nlm.nih.gov/pubmed/23240010 http://dx.doi.org/10.1371/journal.pone.0051281

Ejemplares similares

Effect of Lipopolysaccharide on Glucocorticoid Receptor Function in Control Nasal Mucosa Fibroblasts and in Fibroblasts from Patients with Chronic Rhinosinusitis with Nasal Polyps and Asthma
por: Fernández-Bertolín, Laura, et al.
Publicado: (2015)

MP29-02* reduces eosinophil survival induced by epithelial cell secretions from nasal mucosa
por: Roca-Ferrer, Jordi, et al.
Publicado: (2015)

133 Corticosteroid Rreatment Reduces Tissue Eosinophilia and the Expression of Matrix Metalloproteinases (MMP-1, MMP-2, MMP-7, MMP-9) and Their Tissue Inhibitor (TIMP-1) in Nasal Polyps
por: de Borja Callejas, Fco, et al.
Publicado: (2012)

Reconstituted Human Upper Airway Epithelium as 3-D In Vitro Model for Nasal Polyposis
por: de Borja Callejas, Francisco, et al.
Publicado: (2014)

Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells
por: Mullol, Joaquim, et al.
Publicado: (2011)

Effect of MP‐AzeFlu compared to monotherapy on COX‐2, PGE(2), and EP2 gene expression in upper airway mucosa
por: Vicens‐Artes, Sonia, et al.
Publicado: (2022)

Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers
por: Roca-Ferrer, Jordi, et al.
Publicado: (2018)

551 The Impact of Nasal Polyposis on Quality of Life Using the Eq-5d Health Profile
por: Alobid, Isam, et al.
Publicado: (2012)

132 Characterization of 2 Epithelial Cell Air-Liquid Interface (ALI) Culture Models for Human Healthy Nasal Mucosa and Nasal Polyps
por: de Borja Callejas, Fco, et al.
Publicado: (2012)

Management of Mechanical Nasal Obstruction Isolated or Associated to Upper Airway Inflammatory Diseases in Real Life: Use of both Subjective and Objective Criteria
por: Merma-Linares, Carla, et al.
Publicado: (2023)

Nasal polyps, aspirin sensitivity, and late onset asthma are crucial to identify severe asthma. clinicaltrials.gov id : nct01513837
por: Castillo, José A, et al.
Publicado: (2015)

Prostaglandin E2 receptors in asthma and in chronic rhinosinusitis/nasal polyps with and without aspirin hypersensitivity
por: Machado-Carvalho, Liliana, et al.
Publicado: (2014)

Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study)
por: Jaume, Francesca, et al.
Publicado: (2018)

Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study)
por: Mullol, Joaquim, et al.
Publicado: (2012)

Reply
por: Mullol, Joaquim, et al.
Publicado: (2020)

Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa
por: Vicens‐Artés, Sònia, et al.
Publicado: (2022)

Olfactory dysfunction during COVID-19 pandemic()
por: Izquierdo-Domínguez, Adriana, et al.
Publicado: (2020)

Pérdida del sentido del olfato durante la pandemia COVID-19
por: Izquierdo-Domínguez, Adriana, et al.
Publicado: (2020)

Olfactory Dysfunction in Mental Illness
por: Marin, Concepció, et al.
Publicado: (2023)

Case of Intolerance to Aspirin
por: Clyne, Charles
Publicado: (1920)

Reference Gene Validation for RT–qPCR in PBMCs from Asthmatic Patients with or without Obesity
por: Bantulà, Marina, et al.
Publicado: (2022)

Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma
por: Castillo, José Antonio, et al.
Publicado: (2023)

The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries
por: Mullol, Joaquim, et al.
Publicado: (2020)

Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design
por: Muñoz-Cano, Rosa, et al.
Publicado: (2013)

Nasal polyps in patients with asthma: prevalence, impact, and management challenges
por: Langdon, Cristobal, et al.
Publicado: (2016)

Aspirin Intolerance: Experimental Models for Bed-to-Bench
por: Yamashita, Masamichi
Publicado: (2016)

Montelukast Has no Impact on the Systemic Production of TGFβ-1 in Patients with Nasal Polyposis Associated with Aspirin Intolerance
por: Pezato, Rogério, et al.
Publicado: (2021)

Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study)
por: Castillo-López, Irma Yolanda, et al.
Publicado: (2020)

Differences in Inflammatory Cytokine Profile in Obesity-Associated Asthma: Effects of Weight Loss
por: Bantulà, Marina, et al.
Publicado: (2022)

Expression of COX-1, COX-2, 5-LOX and [Formula: see text] in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease
por: Vorsprach, Monique, et al.
Publicado: (2019)

Consensus on the management of united airways disease with type 2 inflammation: a multidisciplinary Delphi study
por: Blanco-Aparicio, Marina, et al.
Publicado: (2023)

Leukotriene-related Gene Polymorphisms in Patients with Aspirin-intolerant Urticaria and Aspirin-intolerant Asthma: Differing Contributions of ALOX5 Polymorphism in Korean Population
por: Kim, Seung-Hyun, et al.
Publicado: (2005)

COX-2 and EGFR: Partners in Crime Split by Aspirin
por: Patrignani, Paola, et al.
Publicado: (2015)

A Case of Chlorpheniramine Maleate-Induced Hypersensitivity With Aspirin Intolerance
por: Kim, Min-Hye, et al.
Publicado: (2011)

COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma
por: Harrington, Louise S., et al.
Publicado: (2008)

Aspirin for the prevention and treatment of pre‐eclampsia: A matter of COX‐1 and/or COX‐2 inhibition?
por: Mirabito Colafella, Katrina M., et al.
Publicado: (2019)

Diagnostic tools in Rhinology EAACI position paper
por: Scadding, Glenis, et al.
Publicado: (2011)

Association of GPIa and COX‐2 gene polymorphism with aspirin resistance
por: Wang, Hui, et al.
Publicado: (2017)

Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management
por: Thakker, Ravi A., et al.
Publicado: (2022)

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease
por: Miller, B, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vclesbbvftf0dbceoh3ki6pea8